 SOMERSET, N.J.--BUSINESS WIRE--Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that members of its executive leadership team will present at two upcoming investor conferences. On June 7, 2022 at 1:00 p.m. ET, the Company will present at the William Blair Annual Growth Stock Conference. On June 8, 2022, at 8:00 a.m. ET, the Company wil 